AstraZeneca PLC (AZN) vs Cigna Corporation (CI)
AZN leads on 10 of 17 compared metrics, though CI is the cheaper stock.
A side-by-side comparison of AstraZeneca PLC and Cigna Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 13, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
Total return — AZN vs CI
growth of $100 · last 30yAZN +723.4%CI +2330.7%CI compounded faster
AZN CI
AZN vs CI: by the numbers
- •AZN is the larger company ($277.22B vs $78.83B market cap).
- •CI trades at the lower earnings multiple (12.64 vs 26.92 P/E).
- •AZN converts more revenue to profit (17.19% vs 2.26% net margin).
- •AZN grew revenue faster over the past five years (16.99% vs 11.28% CAGR).
- •CI pays the higher dividend yield (2.06% vs 1.79%).
Which is better, AZN or CI?
Metric tally: AZN 10 · CI 7It depends on what you're optimizing for:
ValueCI(lower P/E)
GrowthAZN(faster 5Y revenue CAGR)
IncomeCI(higher dividend yield)
QualityAZN(higher ROIC)
Valuation
| Metric | AZN | CI |
|---|---|---|
| P/E ratio | 26.92 | 12.64● |
| Forward P/E | 15.33 | 8.91● |
| P/S ratio | 4.62 | 0.28● |
| P/B ratio | 5.90 | 1.87● |
| PEG ratio | 0.14● | 0.15 |
| EV / EBITDA | 14.92 | 8.41● |
| FCF yield | 3.26% | 9.73%● |
Profitability
| Metric | AZN | CI |
|---|---|---|
| Gross margin | 81.68%● | 9.30% |
| Operating margin | 23.69%● | 3.42% |
| Net margin | 17.19%● | 2.26% |
| ROE | 21.95%● | 14.90% |
| ROIC | 13.03%● | 7.35% |
Dividends
| Metric | AZN | CI |
|---|---|---|
| Dividend yield | 1.79% | 2.06%● |
| Payout ratio | 48.48% | 27.53% |
Growth (annualized)
| Metric | AZN | CI |
|---|---|---|
| Revenue CAGR (5Y) | 16.99%● | 11.28% |
| EPS CAGR (5Y) | 22.02%● | -0.76% |
| FCF CAGR (5Y) | 18.52%● | -2.03% |
| Total return CAGR (5Y) | 11.03%● | 6.19% |
Frequently asked
- Which is better, AZN or CI?
- It depends on your goal. value: CI (lower P/E); growth: AZN (faster 5Y revenue CAGR); income: CI (higher dividend yield); quality: AZN (higher ROIC). Across all compared metrics, AZN leads 10 to 7.
- Is AZN or CI cheaper?
- On trailing earnings, CI is cheaper: AZN trades at a 26.92 P/E and CI at 12.64.
- Which has grown faster, AZN or CI?
- Over the past five years, AZN grew revenue faster — AZN at a 16.99% CAGR versus CI at 11.28%.
- Does AZN or CI pay a bigger dividend?
- AZN yields 1.79% and CI yields 2.06% based on trailing dividends and the latest price.
- Is AZN or CI more profitable?
- AZN runs the higher net margin — AZN at 17.19% versus CI at 2.26%.
- Which has been the better investment, AZN or CI?
- Over the past 10-year, AZN delivered the higher annualized total return — AZN at 15.77% versus CI at 9.91%. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
AstraZeneca P/E ratioCigna P/E ratioAstraZeneca dividend yieldCigna dividend yieldAstraZeneca ROECigna ROEAstraZeneca operating marginCigna operating marginAstraZeneca revenue growthCigna revenue growthAstraZeneca free cash flowCigna free cash flow
AstraZeneca & Cigna appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 13, 2026.